Nuclear factor-κB accounts for the repressor effects of high stromal cell-derived factor-1α levels on Tac1 expression in nontumorigenic breast cells

Kelly E. Corcoran, Pranela Rameshwar

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Stromal cell-derived factor-1α (SDF-1α) is a CXC chemokine that interacts with CXCR4 receptor. Tac1 encodes peptides belonging to the tachykinins, including substance P. SDF-1α production is decreased in Tac1 knockdown breast cancer cells and is also reduced in these cancer cells following contact with bone marrow stroma when Tac1 expression is increased. Here, we report on the effects of relatively high and low SDF-1α levels on Tac1 expression in nontumorigenic breast cells MCF12A. Reporter gene assays, Northern analyses, and ELISA for substance P showed increased Tac1 expression at 20 and 50 ng/mL SDF-1α and reduced expression at 100 ng/mL. Omission of the untranslated region showed a dose-dependent effect of SDF-1α on reporter gene activity, suggesting that receptor desensitization cannot account for the suppressive effects at 100 ng/mL SDF-1α. Tac1 expression at high SDF-1α involves an intracellular signaling pathway that incorporates the activation of phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-AKT-nuclear factor-κB (NF-κB). The major repressive effect occurs via NF-κB located within exon 1. In summary, NF-κB is involved in the repression of Tac1 at higher levels of SDF-1α in MCF12A. These results are relevant to dysfunction of Tac1 in breast cancer cells and also provide insights on the behavior of breast cancer cells as they traverse across gradient changes of SDF-1α.

Original languageEnglish (US)
Pages (from-to)373-381
Number of pages9
JournalMolecular Cancer Research
Volume5
Issue number4
DOIs
StatePublished - Apr 1 2007

Fingerprint

Chemokine CXCL12
Breast
Substance P
Breast Neoplasms
Reporter Genes
Phosphatidylinositol 3-Kinase
CXCR4 Receptors
Untranslated Regions
CXC Chemokines
Tachykinins
1-Phosphatidylinositol 4-Kinase
Exons
Bone Marrow
Enzyme-Linked Immunosorbent Assay
Peptides

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Oncology
  • Cancer Research

Cite this

@article{1e9c80ea5d274f11bc1fcad66a3321f6,
title = "Nuclear factor-κB accounts for the repressor effects of high stromal cell-derived factor-1α levels on Tac1 expression in nontumorigenic breast cells",
abstract = "Stromal cell-derived factor-1α (SDF-1α) is a CXC chemokine that interacts with CXCR4 receptor. Tac1 encodes peptides belonging to the tachykinins, including substance P. SDF-1α production is decreased in Tac1 knockdown breast cancer cells and is also reduced in these cancer cells following contact with bone marrow stroma when Tac1 expression is increased. Here, we report on the effects of relatively high and low SDF-1α levels on Tac1 expression in nontumorigenic breast cells MCF12A. Reporter gene assays, Northern analyses, and ELISA for substance P showed increased Tac1 expression at 20 and 50 ng/mL SDF-1α and reduced expression at 100 ng/mL. Omission of the untranslated region showed a dose-dependent effect of SDF-1α on reporter gene activity, suggesting that receptor desensitization cannot account for the suppressive effects at 100 ng/mL SDF-1α. Tac1 expression at high SDF-1α involves an intracellular signaling pathway that incorporates the activation of phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-AKT-nuclear factor-κB (NF-κB). The major repressive effect occurs via NF-κB located within exon 1. In summary, NF-κB is involved in the repression of Tac1 at higher levels of SDF-1α in MCF12A. These results are relevant to dysfunction of Tac1 in breast cancer cells and also provide insights on the behavior of breast cancer cells as they traverse across gradient changes of SDF-1α.",
author = "Corcoran, {Kelly E.} and Pranela Rameshwar",
year = "2007",
month = "4",
day = "1",
doi = "https://doi.org/10.1158/1541-7786.MCR-06-0396",
language = "English (US)",
volume = "5",
pages = "373--381",
journal = "Molecular Cancer Research",
issn = "1541-7786",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

TY - JOUR

T1 - Nuclear factor-κB accounts for the repressor effects of high stromal cell-derived factor-1α levels on Tac1 expression in nontumorigenic breast cells

AU - Corcoran, Kelly E.

AU - Rameshwar, Pranela

PY - 2007/4/1

Y1 - 2007/4/1

N2 - Stromal cell-derived factor-1α (SDF-1α) is a CXC chemokine that interacts with CXCR4 receptor. Tac1 encodes peptides belonging to the tachykinins, including substance P. SDF-1α production is decreased in Tac1 knockdown breast cancer cells and is also reduced in these cancer cells following contact with bone marrow stroma when Tac1 expression is increased. Here, we report on the effects of relatively high and low SDF-1α levels on Tac1 expression in nontumorigenic breast cells MCF12A. Reporter gene assays, Northern analyses, and ELISA for substance P showed increased Tac1 expression at 20 and 50 ng/mL SDF-1α and reduced expression at 100 ng/mL. Omission of the untranslated region showed a dose-dependent effect of SDF-1α on reporter gene activity, suggesting that receptor desensitization cannot account for the suppressive effects at 100 ng/mL SDF-1α. Tac1 expression at high SDF-1α involves an intracellular signaling pathway that incorporates the activation of phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-AKT-nuclear factor-κB (NF-κB). The major repressive effect occurs via NF-κB located within exon 1. In summary, NF-κB is involved in the repression of Tac1 at higher levels of SDF-1α in MCF12A. These results are relevant to dysfunction of Tac1 in breast cancer cells and also provide insights on the behavior of breast cancer cells as they traverse across gradient changes of SDF-1α.

AB - Stromal cell-derived factor-1α (SDF-1α) is a CXC chemokine that interacts with CXCR4 receptor. Tac1 encodes peptides belonging to the tachykinins, including substance P. SDF-1α production is decreased in Tac1 knockdown breast cancer cells and is also reduced in these cancer cells following contact with bone marrow stroma when Tac1 expression is increased. Here, we report on the effects of relatively high and low SDF-1α levels on Tac1 expression in nontumorigenic breast cells MCF12A. Reporter gene assays, Northern analyses, and ELISA for substance P showed increased Tac1 expression at 20 and 50 ng/mL SDF-1α and reduced expression at 100 ng/mL. Omission of the untranslated region showed a dose-dependent effect of SDF-1α on reporter gene activity, suggesting that receptor desensitization cannot account for the suppressive effects at 100 ng/mL SDF-1α. Tac1 expression at high SDF-1α involves an intracellular signaling pathway that incorporates the activation of phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-AKT-nuclear factor-κB (NF-κB). The major repressive effect occurs via NF-κB located within exon 1. In summary, NF-κB is involved in the repression of Tac1 at higher levels of SDF-1α in MCF12A. These results are relevant to dysfunction of Tac1 in breast cancer cells and also provide insights on the behavior of breast cancer cells as they traverse across gradient changes of SDF-1α.

UR - http://www.scopus.com/inward/record.url?scp=34248171306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248171306&partnerID=8YFLogxK

U2 - https://doi.org/10.1158/1541-7786.MCR-06-0396

DO - https://doi.org/10.1158/1541-7786.MCR-06-0396

M3 - Article

C2 - 17409218

VL - 5

SP - 373

EP - 381

JO - Molecular Cancer Research

JF - Molecular Cancer Research

SN - 1541-7786

IS - 4

ER -